B & T Capital Management Dba Alpha Capital Management Gilead Sciences, Inc. Transaction History

B & T Capital Management Dba Alpha Capital Management

$497 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$73.27 - $83.09 $128,442 - $145,656	1,753 Added 4.0%	45,624 $3.7 Million
Q3 2023 Oct 17, 2023	BUY	$73.94 - $80.67 $368,369 - $401,897	4,982 Added 12.81%	43,871 $3.29 Million
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $2.42 Million - $3.48 Million	38,889 New	38,889 $3.34 Million
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $2.75 Million - $3.19 Million	-38,030 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $59,686 - $76,449	953 Added 2.57%	38,030 $2.84 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $173,028 - $190,326	-2,808 Reduced 7.04%	37,077 $2.41 Million
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $111,455 - $123,027	1,783 Added 4.68%	39,885 $2.53 Million
Q2 2019 Aug 01, 2019	BUY	$61.87 - $69.38 $17,756 - $19,912	287 Added 0.76%	38,102 $2.57 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $92,544 - $103,674	1,480 Added 4.07%	37,815 $2.46 Million
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $49,703 - $64,859	821 Added 2.31%	36,335 $2.27 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $54,457 - $60,294	764 Added 2.2%	35,514 $2.74 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $177,900 - $207,514	2,742 Added 8.57%	34,750 $2.46 Million
Q1 2018 Apr 20, 2018	SELL	$72.84 - $88.8 $75,025 - $91,464	-1,030 Reduced 3.12%	32,008 $2.41 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $71,648 - $84,104	-1,007 Reduced 2.96%	33,038 $2.37 Million
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $2.45 Million - $2.91 Million	34,045	34,045 $2.76 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B & T Capital Management Dba Alpha Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on B & T Capital Management Dba Alpha Capital Management with notifications on news.

Account